Our Science
Disease Area
- Multiple
Modality
- Multiple
Disease Area
- Multiple
Modality
- Multiple
By: Dr. Alison Betts, Vice President of Scientific Collaborations and Fellow of Modeling & Simulation of Applied BioMath
Disease Area
- Oncology
- Immuno-oncology
Modality
- Multiple

Collaboration with Genmab - Presented at SITC 2021
Disease Area
- Immuno-oncology
Modality
- Bispecific

Collaboration with Antengene - Presented at SITC 2021
Disease Area
- Oncology
Modality
- Bispecific
Published in Pharma Tech Outlook Magazine
Disease Area
- Multiple
Modality
- Bispecific
- mAb
Published in Clinical Pharmacology & Therapeutics
Disease Area
- Oncology
Modality
- Bispecific

Collaboration with Pfizer - Presented by Alison Betts, Applied BioMath
Disease Area
- Oncology
Modality
- Bispecific

Collaboration with Jounce - Presented by Dr. John M. Burke, Applied BioMath
Disease Area
- Immuno-oncology
Modality
- Bispecific
Published in AAPS Newsmagazine
Disease Area
- Multiple
Modality
- Multiple

Collaboration with Jounce
Disease Area
- Immuno-oncology
Modality
- Bispecific

Collaboration with Pfizer - Presented at AAPS 2019 PharmSci 360
Disease Area
- Oncology
Modality
- Bispecific